Brainstorm Cell Therapeutics shares owned by Advisor Group Holdings
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Advisor Group Holdings
from 13F filings
Historical chart of Advisor Group Holdings investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Advisor Group Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.9k | 11k | 0.27 |
| 2023-09-30 | $3.0k | 15k | 0.20 |
| 2023-06-30 | $22k | 11k | 2.06 |
| 2023-03-31 | $36k | 11k | 3.30 |
| 2022-12-31 | $16k | 11k | 1.47 |
| 2022-09-30 | $48k | 11k | 4.41 |
| 2022-06-30 | $32k | 11k | 2.94 |
| 2022-03-31 | $36k | 11k | 3.31 |
| 2021-12-31 | $38k | 10k | 3.79 |
| 2021-09-30 | $36k | 11k | 3.30 |
| 2021-06-30 | $41k | 11k | 3.77 |
| 2021-03-31 | $91k | 24k | 3.77 |
| 2020-12-31 | $103k | 22k | 4.74 |
| 2020-09-30 | $969k | 56k | 17.27 |
| 2020-06-30 | $86k | 7.8k | 11.00 |
| 2020-03-31 | $40k | 8.5k | 4.71 |